Novartis India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE234A01025
  • NSEID: NOVARTIND
  • BSEID: 500672
INR
2,047.55
61.15 (3.08%)
BSENSE

Oct 09

BSE+NSE Vol: 53.55 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 333626,
    "name": "Novartis India",
    "stock_name": "Novartis India",
    "full_name": "Novartis India Ltd",
    "name_url": "stocks-analysis/novartis-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,047.55",
    "chg": 61.15,
    "chgp": "3.08%",
    "dir": 1,
    "prev_price": "1,986.40",
    "mcapval": "4,889.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500672,
    "symbol": "NOVARTIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE234A01025",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "53.55 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/novartis-india-333626-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Novartis India share price jumps 10% | What lies ahead for the stock?",
        "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPVTEyTmt5bDR5OTZsMUwzczdKa293R291a2EwRnlsaVdhQzZabDBQOThJRkdrYXZaam5Wb2FHTGx1NVE1SUdBTkxXWlcwcUJLbmlnS2dYTzFSNVZoSG1VU0VVYmJGWFFnWS1nY3JxVWkyM1h0WEszel9OTndlejB0NnpONzQyU0J2aEppUEw0WTZXb0lMdVNWSllrSng0U1VSUEVsdlJyX1Y0VkptTlRiWGU1ZnJYSzVBRXEwZ2FVelRicjk3STRCblI2RG9oRmZINjFJWm5R0gHWAUFVX3lxTE9VMTJOa3lsNHk5NmwxTDNzN0prb3dHb3VrYTBGeWxpV2FDNlpsMFA5OElGR2thdlpqblZvYUdMbHU1UTVJR0FOTFdaVzBxQktuaWdLZ1hPMVI1VmhIbVVTRVViYkZYUWdZLWdjcnFVaTIzWHRYSzN6X05Od2V6MHQ2ek43NDJTQnZoSmlQTDRZNldvSUx1U1ZKWWtKeDRTVVJQRWx2UnJfVjRWSm1OVGJYZTVmclhLNUFFcTBnYVV6VGJyOTdJNEJuUjZEb2hGZkg2MUlablE?oc=5",
        "imagepath": "",
        "date": "2026-10-05 10:52:08",
        "description": "Novartis India share price jumps 10% | What lies ahead for the stock?  Livemint..."
      },
      {
        "title": "Novartis India shares soar 18% to record high; extend 9-day gains to 74%; here\\'s why",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-10 12:50:35",
        "description": "Novartis India shares soar 18% to record high; extend 9-day gains to 74%; here\\'s why  Business Today..."
      },
      {
        "title": "Novartis India zooms 51% in 3 days; what\\'s driving the pharma stock?",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-10 10:56:54",
        "description": "Novartis India zooms 51% in 3 days; what\\'s driving the pharma stock?  Business Standard<br>Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%  BusinessLine<br>Novartis India to acquire Pfizer hypertension brand Minipress for 1250 crore  pharma.economictimes.indiatimes.com<br>Upper Circuit: Novartis India shares gain for eighth straight day to a record high  cnbctv18.com<br>Novartis India to Acquire Minipress, Minipres Trademarks From Pfizer for Rs 1,250 Crore  Medical Dialogues<br>Novartis India shares surge 13%, hit fresh 52-week high on entering ophthalmology therapy  Upstox<br>Novartis India acquires Pfizer brands for $132m  Yahoo Finance<br>Minipress changes hands: Novartis India buys Pfizer brands for Rs 1,250 crore  Moneycontrol.com<br>Novartis India Ltd to acquire BP drug trademarks from Pfizer Inc, for 1,250 crore  BusinessLine<b..."
      },
      {
        "title": "Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-09 21:28:43",
        "description": "Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%  BusinessLine..."
      },
      {
        "title": "Novartis India Ltd leads gainers in \\'B\\' group",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-09 12:56:03",
        "description": "Novartis India Ltd leads gainers in \\'B\\' group  Business Standard..."
      },
      {
        "title": "Novartis India shares zoom 20% to hit record high; Minipress deal fuels rally",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-09 11:28:26",
        "description": "Novartis India shares zoom 20% to hit record high; Minipress deal fuels rally  Business Today..."
      },
      {
        "title": "Novartis faces third clinical-trial setback in a week as muscle drug fails",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-08 13:18:28",
        "description": "Novartis faces third clinical-trial setback in a week as muscle drug fails  Business Standard..."
      },
      {
        "title": "Pfizer shares hit 52-week low after Minipress XL discontinuation; Novartis zooms 13%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-08 13:08:44",
        "description": "Pfizer shares hit 52-week low after Minipress XL discontinuation; Novartis zooms 13%  Business Today..."
      },
      {
        "title": "Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-08 10:31:10",
        "description": "Novartis enters into exclusive promotion and distribution agreement with Novartis Healthcare  Business Standard..."
      }
    ],
    "total": 13,
    "sid": "333626",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/novartis-india-333626"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "07-Oct-2026",
      "details": "Intimation of the Credit Ratings assigned by CARE Ratings Limited.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration Of Raising Of Funds Through The Issuance Of Equity Shares Of The Company.",
      "datetime": "05-Oct-2026",
      "details": "Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2026 inter alia to consider and approve the raising of funds through the issuance of equity shares of our Company with a face value of ? 5 each (Equity Shares) by way of a rights issue to its eligible equity shareholders (Rights Issue).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change of Company Name",
      "datetime": "01-Oct-2026",
      "details": "Intimation of the Change of Name of Company from Novartis India Limited to Evonile Pharma Limited pursuant to the Fresh Certificate of Incorporation dated October 01 2026 issued by Ministry of Corporate Affairs.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "03 Nov 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novartis India Ltd has declared <strong>500%</strong> dividend, ex-date: 23 Jul 25",
          "dt": "2025-07-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Credit Rating

07-Oct-2026 | Source : BSE

Intimation of the Credit Ratings assigned by CARE Ratings Limited.

Board Meeting Intimation for Consideration Of Raising Of Funds Through The Issuance Of Equity Shares Of The Company.

05-Oct-2026 | Source : BSE

Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2026 inter alia to consider and approve the raising of funds through the issuance of equity shares of our Company with a face value of ? 5 each (Equity Shares) by way of a rights issue to its eligible equity shareholders (Rights Issue).

Announcement under Regulation 30 (LODR)-Change of Company Name

01-Oct-2026 | Source : BSE

Intimation of the Change of Name of Company from Novartis India Limited to Evonile Pharma Limited pursuant to the Fresh Certificate of Incorporation dated October 01 2026 issued by Ministry of Corporate Affairs.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

03 Nov 2026

stock-summary
DIVIDEND

Novartis India Ltd has declared 500% dividend, ex-date: 23 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available